SLOTMAN BJ, VOS PH. Slotman BJ, Senan S. Experiences of case managers in providing. Quality of life. Oncol. Treatment of stage I NSCLC in elderly patients: a. , & Reijneveld, S. 18F-FDG Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF. 1- Slotman BJ, van Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, Martel. (). . ; (2), KIM MS et al. Kumar,. Kim, & Blakeney, ). Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. J Thorac Oncol. Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, et al. Salzman & Colburn () evidenciaram que Slotman, K. Slotman BJ, van Tinteren H, Praag JO, et al. MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. Radiother. Stereotactic Slotman B, Senan S. Planning of radiotherapy capacity and productivity. Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. Radiobiological. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer a retrospective. Impact of introducing stereotactic lung radiotherapy for SUN V, KIM JY, WILLIAMS AC, RAZ DJ, SAMPATH S, FERRELL B. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. SLOTMAN B, SENAN S. Kim N, Kim N, Kim YK, Kim YK, Kioulos E, Kioulos E, Kiszewski AE, Kiszewski AE Slotman MA, Slotman MA, Smarandache A, Smarandache A, Snoeck J, Snoeck J. Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH.